drugset / Trial / NCT00518921
Capadenoson in Angina Pectoris
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a multi-center and multi-national,randomized, double blind, placebo-controlled, 28-day treatment study with BAY 68-4986 taken orally or a matching placebo.
Timeline
- Start
- 2008-03
- Primary completion
- —
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capadenoson | Small molecule | 1 mg | Oral |
| Subject | Capadenoson | Small molecule | 2 mg | Oral |
| Subject | Capadenoson | Small molecule | 4 mg | Oral |